Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
$5.38
+4.5%
$5.38
$3.07
$12.39
$47.88M-0.3413,124 shs53,100 shs
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
$0.77
-3.1%
$0.92
$0.65
$17.48
$107.19M-2.211.72 million shs498,100 shs
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
$1.54
-1.3%
$1.55
$0.60
$4.69
$128.53M1.271.47 million shs2.39 million shs
So-Young International Inc. stock logo
SY
So-Young International
$1.23
-0.8%
$1.17
$0.83
$2.83
$122.07M0.975,390 shs30,600 shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
0.00%0.00%0.00%0.00%-48.32%
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
0.00%-11.10%-19.39%-6.61%-93.99%
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
0.00%0.00%0.00%+0.65%-53.47%
So-Young International Inc. stock logo
SY
So-Young International
0.00%-6.82%+6.03%+8.85%-50.40%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
0.8641 of 5 stars
0.05.00.00.01.02.50.6
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
2.6574 of 5 stars
3.00.00.04.70.03.31.3
So-Young International Inc. stock logo
SY
So-Young International
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
N/AN/AN/AN/A
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
N/AN/AN/AN/A
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
2.00
Hold$2.5363.96% Upside
So-Young International Inc. stock logo
SY
So-Young International
N/AN/AN/AN/A

Current Analyst Ratings

Latest LIFW, SY, ADEX, and NGM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/12/2024
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
2/28/2024
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
2/28/2024
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform$4.00 ➝ $1.55
2/27/2024
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Neutral
(Data available from 5/20/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
$19.62M2.44N/AN/A($6.81) per share-0.79
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
$7.70M13.92$2.95 per share0.26$8.88 per share0.09
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
$4.42M29.10N/AN/A$1.80 per share0.86
So-Young International Inc. stock logo
SY
So-Young International
$1.50B0.08$0.10 per share12.86$3.64 per share0.34

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
-$18.66MN/A0.00N/AN/AN/A-41.90%N/A
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
-$56.35M-$6.26N/AN/A-724.07%-3.70%-1.76%9/6/2024 (Estimated)
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
-$142.38M-$1.72N/AN/AN/A-3,223.34%-77.85%-67.76%N/A
So-Young International Inc. stock logo
SY
So-Young International
$3M$0.0341.01N/A1.37%0.81%0.65%5/27/2024 (Estimated)

Latest LIFW, SY, ADEX, and NGM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2024Q4 2023
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
N/A-$1.91-$1.91-$2.13N/A$0.73 million
3/20/2024Q4 2023
So-Young International Inc. stock logo
SY
So-Young International
N/A$0.03+$0.03$0.03N/A$55.01 million
3/11/2024Q4 2023
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
-$0.37-$0.33+$0.04-$0.33$2.00 million$0.17 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
N/AN/AN/AN/AN/A
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
N/AN/AN/AN/AN/A
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
N/AN/AN/AN/AN/A
So-Young International Inc. stock logo
SY
So-Young International
N/AN/AN/AN/AN/A

Latest LIFW, SY, ADEX, and NGM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2024
So-Young International Inc. stock logo
SY
So-Young International
--$0.064/11/20244/12/20244/29/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
N/A
0.14
0.15
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
0.57
0.23
0.47
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
N/A
7.79
7.79
So-Young International Inc. stock logo
SY
So-Young International
N/A
3.19
2.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
0.80%
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
3.77%
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
75.74%
So-Young International Inc. stock logo
SY
So-Young International
35.31%

Insider Ownership

CompanyInsider Ownership
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
0.32%
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
19.40%
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
35.90%
So-Young International Inc. stock logo
SY
So-Young International
16.70%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Adit EdTech Acquisition Corp. stock logo
ADEX
Adit EdTech Acquisition
78.90 million8.87 millionNot Optionable
MSP Recovery, Inc. stock logo
LIFW
MSP Recovery
100139.97 million112.81 millionOptionable
NGM Biopharmaceuticals, Inc. stock logo
NGM
NGM Biopharmaceuticals
13883.46 million53.50 millionOptionable
So-Young International Inc. stock logo
SY
So-Young International
1,35799.24 million82.67 millionNot Optionable

LIFW, SY, ADEX, and NGM Headlines

Recent News About These Companies

SMIC hikes capex budget to support expansion in 2024

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Adit EdTech Acquisition logo

Adit EdTech Acquisition

NYSE:ADEX
Adit EdTech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or entities. Adit EdTech Acquisition Corp. was incorporated in 2020 and is based in New York, New York. Adit EdTech Acquisition Corp. operates as a subsidiary of Adit Edtech Sponsor, LLC.
MSP Recovery logo

MSP Recovery

NASDAQ:LIFW
MSP Recovery, Inc., doing business as LifeWallet, operates as a healthcare recoveries and data analytics company in the United States and Puerto Rico. The company offers claims recovery services, including services to related parties or third parties to assist entities with pursuit of claims recovery rights. It is also developing LifeWallet, a platform for real-time analytics at the point of care which helps in identifying the primary insurer and assisting providers in receiving customary rates for accident-related treatment. MSP Recovery, Inc. was founded in 2014 and is headquartered in Coral Gables, Florida.
NGM Biopharmaceuticals logo

NGM Biopharmaceuticals

NASDAQ:NGM
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company develops NGM707, an immunoglobulin-like transcript 2/ immunoglobulin-like transcript 4 dual antagonist monoclonal antibody that is in Phase I/II clinical trials for the treatment of patients with advanced metastatic solid tumors; and Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of primary sclerosing cholangitis and non-alcoholic steatohepatitis. It also develops NGM120, an GFRAL antagonist antibody, which is in Phase II clinical trial to treat hyperemesis gravidarum; NGM831 and NGM438 which is in phase I/II clinical trial for the treatment of advanced solid tumors; and NGM621, an monoclonal antibody in Phase II clinical trials for the treatment of geographic atrophy. The company has research collaboration, product development, and license agreements with Merck Sharp & Dohme Corp.; and a collaboration agreement with Merck to focus primarily on the identification, research and development of collaboration compounds directed to targets in the fields of ophthalmology and cardiovascular or metabolic, or CVM, disease, including heart failure. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California.
So-Young International logo

So-Young International

NASDAQ:SY
So-Young International Inc. operates an online platform for consumption healthcare services in the People's Republic of China and internationally. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment. The company offers So-Young Mobile App that offers users medical aesthetic knowledge and experience to reach an informed medical aesthetic treatment decision and make reservations for treatment with medical professionals and medical aesthetic institutions; So-Young Beauty; So-Young Q&A for communications among users and doctors; So-Young PASS, an online aesthetic beauty skin care pass; So-Young Business College, an online training platform for medical aesthetic practitioners, including medical professionals, managers, and medical aesthetic consultants; and medical aesthetic community content; and other services through its website soyoung.com. It also provides content in various media formats on its online platform generated by users, including professional generated, user generated, professional user generated, and doctor generated content; information on medical aesthetic treatment trends; ratings and reviews on treatment experiences; blogs under the name Beauty Diaries; reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; software as a service; and engages in research and development, production, sales, and agency of laser and other optoelectronic medical beauty equipment. In addition, the company offers internet information and technology advisory, management consulting, Internet culture, and micro finance services, as well as sells medical equipment. The company was founded in 2013 and is headquartered in Beijing, China.